Alvotech and Dr Reddy’s collaborate on biosimilar AVT03 EP News Bureau May 22, 2024 Dr Reddy’s gets exclusive commercialisation rights of denosumab in the US as well as semi-exclusive rights in Europe and UK
Alvotech’s AVT05 emerges as leading contender for Simponi biosimilar in rheumatoid arthritis:… EP News Bureau Oct 10, 2023 In May 2023, Alvotech and Advanz Pharma announced an extended strategic partnership with plans to supply and commercialise five…
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and… EP News Bureau Mar 2, 2021 Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution…
Alvotech in partnership with Cipla Gulf EP News Bureau Jul 29, 2019 The partnership will aid in the commercialisation of key biosimilar in select emerging markets